2024 brought some major advancements in medicine. That includes the approval of "innovative" drugs like Tryvio for high blood pressure, Neffy for severe allergic reactions and Dupixent for chronic ...

GoodRx Holdings (GDRX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on December 16. Analyst Michael Cherny from Leerink Partners reiterated a Buy ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...